Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
5-Bromo-N[2-(Dimethylamino)Ethyl]-9-Aminoacridine-4-Carboxamide
- Development stage
- Discontinued
- Modality
- Small Molecules
01
Overview
**5-Bromo-N[2-(Dimethylamino)Ethyl]-9-Aminoacridine-4-Carboxamide** is an experimental small molecule belonging to the acridine class of compounds. It is a brominated derivative of N-[2-(dimethylamino)ethyl]-9-aminoacridine, which has been studied for its potential antitumor activity. Acridine derivatives are known for their DNA intercalating properties, and this compound likely exerts its effects by binding to DNA, thereby interfering with DNA replication and transcription processes in tumor cells. The compound has not been approved for clinical use and remains at the experimental stage, with no reported clinical trials or marketed formulations. Its primary research interest lies in oncology as a potential antitumor agent due to its structural similarity to other DNA-binding acridines[1][7].
- Other names
- 9-Amino-4-bromo-5-{[2-(dimethylamino)ethyl]carbamoyl}acridinium9-ammonio-4-bromo-5-{[2-(dimethylamino)ethyl]carbamoyl}acridinium9-amino-4-bromo-5-{[2-(diméthylammonio)éthyl]carbamoyl}acridinium
02
Targets
DNA
Beyond the preview
Go deeper on 5-Bromo-N[2-(Dimethylamino)Ethyl]-9-Aminoacridine-4-Carboxamide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 5-Bromo-N[2-(Dimethylamino)Ethyl]-9-Aminoacridine-4-Carboxamide.